Globus Medical, Inc. (GMED) fell 6.42 percent to $52.72 on Monday after announcing leadership changes and preliminary second-quarter sales results.
Shares opened at $53.36 and have traded between $52.22 and $53.75 so far, compared to a previous close of $56.34 on the New York Stock Exchange. The stock's 52-week range is $52.22 to $94.93, with a volume of 2.06 million shares against an average of 1.54 million.
Keith Pfeil, currently EVP, COO, and CFO, will become President and CEO on July 18, succeeding Daniel Scavilla, who is resigning to pursue another opportunity. Kyle Kline will step in as SVP and CFO.
The company expects second quarter 2025 sales of approximately $745.3 million, up 18.4 percent year over year, with base business sales of $650.8 million, a 3.3 percent increase excluding contributions from Nevro.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.